BSEBoard Meeting▲ PositiveResults6d ago
Galaxy Surfactants Ltd
Meeting of Board of Directors of the Company was held as scheduled today i.e. November 04, 2026 and the Board inter-alia has approved following:
1) Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter & half year ended September 30, 2026
2) Interim Dividend of Rs.18/- per equity share for FY27
3) Re-appointment of Managing Director
4) Change in Company Secretary
5) Appointment of Statutory Auditor
Galaxy Surfactants Ltd has announced its unaudited financial results for the quarter and half-year ended September 30, 2026, along with an interim dividend of Rs.18 per equity share, re-appointment of Managing Director, change in Company Secretary, and appointment of Statutory Auditors.
NSEOutcome of Board Meeting▲ PositiveResults6d ago
Entero Healthcare Solutions Limited
Outcome of Board Meeting
Entero Healthcare Solutions Limited has announced its unaudited financial results for the quarter and half year ended September 30, 2026, with a net profit of Rs. 191.44 crore and a revenue from operations of Rs. 1,145.71 crore.
BSECompany Update▲ PositiveResults6d ago
Golkunda Diamonds & Jewellery Ltd
Press release- Unaudited Financial results for the quarter ended 30.09.2026
Golkunda Diamonds & Jewellery Ltd has announced its unaudited financial results for Q2 and H1 FY27, showing a 113.23% and 88.76% YoY PAT growth respectively. The company has also established a new brand, NIBHANA, exclusively focused on lab-grown diamond jewellery, with four retail stores already operational and plans to establish seven more in the near future.
NSEInvestor Presentation▲ PositiveResults6d ago
Aurobindo Pharma Limited
Investor Presentation
Aurobindo Pharma Limited has released its investor presentation for Q2FY27, highlighting a 23.9% year-over-year revenue growth to ₹10,263 Cr, driven by strong performance across all business areas, with a highest-ever quarterly EBITDA of ₹2,156 Cr and a net profit of ₹1,124 Cr.
BSECompany Update▲ PositiveResults6d ago
Stove Kraft Ltd
Investor Presentation
Stove Kraft Ltd has announced its Q2 & H1 FY27 investor presentation, highlighting operational highlights, including highest ever EBIDTA % of 12.9% for Q2 FY27, revenue growth of 23.2% YoY, and strong operating and financial leverage driving EBITDA and PAT growth.
NSEPress Release▲ PositiveResults6d ago
Aurobindo Pharma Limited
Press Release
Aurobindo Pharma Limited has announced its consolidated financial results for the quarter ended September 30, 2026, with revenue from operations increasing by 24% YoY to INR 10,263 Cr, driven by growth across businesses.
BSECompany Update▲ PositiveResults6d ago
Krishna Institute of Medical Sciences Ltd
Press Release
Krishna Institute of Medical Sciences Ltd has announced its unaudited financial results for the 2nd quarter and half-year ended 30th September 2026, showing a growth of 41.3% in total revenue and 34.0% in EBITDA on a year-on-year basis.
BSECompany Update▲ PositiveResults6d ago
Godavari Biorefineries Ltd
Press release for the quarter and half year ended 30th September, 2026
Godavari Biorefineries Ltd reported Q2 FY27 results, with total revenue of Rs. 549.8 Cr and EBITDA of Rs. 10.9 Cr, a turnaround from Q2 FY26's negative EBITDA. The Bio-based Chemicals business saw strong growth, with revenue up 39% YoY and segment EBITDA increasing by 47% YoY.
NSEPress Release▲ PositiveResults6d ago
Godavari Biorefineries Limited
Press Release
Godavari Biorefineries Limited has announced its unaudited financial results for the quarter and half year ended September 30, 2026, showing a turnaround in quarterly performance despite industry headwinds. The company's Bio-based Chemicals business maintained strong momentum, with revenue growing by approximately 39% year-on-year and segment EBITDA increasing by approximately 47% year-on-year.
BSECompany Update▲ PositiveResults6d ago
Aurobindo Pharma Ltd
Submission of Earnings Presentation on Q2 FY27 Financial Results.
Aurobindo Pharma Ltd has announced its Q2 FY27 financial results, with revenue of ₹10,263 Cr, a 23.9% growth YoY, and highest-ever quarterly EBITDA of ₹2,156 Cr at a margin of 21.0%. The company has also launched 10 products in the US market and generated net cash flow of US$ 146mn during the quarter.
BSECompany Update▲ PositiveResults6d ago
Premier Energies Ltd
Investor Presentation on Financial Results for the Quarter ended September 30, 2026
Premier Energies Ltd has released its Q2 FY27 financial results, showing a 38.2% YoY increase in revenue and a 17.8% YoY increase in EBITDA. The company has also highlighted its scale advantage, focused growth strategy, and technology leadership.
BSECompany Update▲ PositiveResults6d ago
Aurobindo Pharma Ltd
Submission of Press Release on Q2 FY27 financial results
Aurobindo Pharma Ltd announced its Q2 FY27 financial results, with revenue from operations increasing by 24% YoY to INR 10,263 Cr, driven by growth across businesses. The company reported a net profit of INR 1,124 Cr and declared an interim dividend of ₹ 7.0 per share.
BSEBoard Meeting▲ PositiveResults6d ago
Aurobindo Pharma Ltd
Submission of outcome of Board Meeting held on November 4, 2026
Aurobindo Pharma Ltd has announced its unaudited financial results for the second quarter and half year ended September 30, 2026, with a standalone profit after tax from continuing operations of Rs. 7,235.8 crore. The company has also approved the payment of an interim dividend of 700% and the re-appointment of a director. Additionally, the company has approved a scheme of amalgamation for the merger of two of its subsidiaries.
BSECompany Update▲ PositiveResults6d ago
Stove Kraft Ltd
Investor Release
Stove Kraft Ltd reported robust Q2 & H1FY27 performance with revenue growth of 23.2% YoY, EBITDA margin of 12.9%, and PAT growth of 35.7% YoY.
NSEPress Release▲ PositiveResults6d ago
Stove Kraft Limited
Press Release
Stove Kraft Limited has reported robust Q2 & H1FY27 performance with revenue growth of 23.2% YoY, EBITDA margin of 12.9%, and PAT growth of 35.7% YoY.
NSEPress Release▲ PositiveResults6d ago
Krishna Institute of Medical Sciences Limited
Press Release
Krishna Institute of Medical Sciences Limited has announced its unaudited financial results for the 2nd quarter and half-year ended 30th September 2026, showing a growth of 41.3% in total revenue and 34.0% in EBITDA on a year-on-year basis.
BSECompany Update▲ PositiveResults6d ago
Jash Engineering Ltd
Investor presentation for the Q2 FY2026-27
Jash Engineering Ltd reported Q2 FY2026-27 revenue of ₹194.9 crore, up 22% YoY, with EBITDA of ₹27.3 crore - up 23% and PAT of ₹14.3 crore - up 30%. The company's consolidated order book stood at ₹955 crore, providing a healthy revenue visibility.
BSECompany Update▲ PositiveResults6d ago
Karnataka Bank Ltd
Transcript of earnings audio call
Karnataka Bank Ltd has announced its Q2FY27 earnings, with the bank achieving its highest ever aggregate business of INR2,07,132 crores as of 30th September, 2026, up by 5% Q-on-Q and 17% Y-o-Y. Gross advances stood at INR92,015 crores as on 30th September, 2026, reflecting a Q-o-Q growth of 6%.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults6d ago
The Karnataka Bank Limited
Analysts/Institutional Investor Meet/Con. Call Updates
The Karnataka Bank Limited has informed the Exchange Transcript of Q2FY27 Earnings Audio Conference Call, which showcases a steady consecutive quarterly expansion powered by stakeholders, customers, and staff under the capable stewardship of the Chairman and the Board.
BSECompany Update▲ PositiveResults6d ago
Jash Engineering Ltd
Investor presentation for the Q2 FY2026-27
Jash Engineering Ltd reported Q2 FY2026-27 revenue of ₹194.9 crore, up 22% YoY, with EBITDA of ₹27.3 crore – up 23% and PAT of ₹14.3 crore - up 30%. The company's consolidated order book stood at ₹955 crore, providing a healthy revenue visibility.